“Nailing down” risk and improving outcomes in early-stage breast cancer
Whether via the strain of academic advancement or hyper-competitive industry-funded drug-development landscape,1 there has been increasing focus to shift c
Related Articles
The NIH Needs Reform: Here are 10 Sensible Suggestions
It is my pleasure to introduce this article by Joseph Marine, MD.
“Nailing down” risk and improving outcomes in early-stage breast cancer
Whether via the strain of academic advancement or hyper-competitive industry-funded drug-development landscape,1 there has been increasing focus to shift c
BellissiMo’s Mo Space
Movember, the month formerly known as November, is a moustache growing charity event held during November each year that raises funds and awareness for men’s…
Medicare’s New Pathway for Transitional Coverage for Emerging Technologies
This Viewpoint discusses the Centers for Medicare & Medicaid Services Transitional Coverage for Emerging Technologies pathway.
Home | Ask Doctor Ed
He’s called Dr. Ed — that’s Edward T. Creagan, MD, a cancer specialist, the first Mayo Clinic doctor board certified in hospice and palliative medicine.…
Psoriasis and risk of new-onset degenerative valvular heart disease: a prospective cohort study
AbstractBackground. Recent evidence indicates that degenerative valvular heart disease (VHD) and psoriasis share overlapping risk factors and simultaneous
The Secrets of Great Teamwork
Over the years, as teams have grown more diverse, dispersed, digital, and dynamic, collaboration has become more complex. But though teams face new challenges, their…